One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. | Zendy

David O. Williams | Zendy; Eugene Braunwald | Zendy; Genell L. Knatterud | Zendy; Joseph D. Babb | Zendy; John Bresnahan | Zendy; M A Greenberg | Zendy; Albert E. Raizner | Zendy; Alan G. Wasserman | Zendy; T. Robertson | Zendy; Rachael Ross | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.

Author(s) -

David O. Williams,

Eugene Braunwald,

Genell L. Knatterud,

Joseph D. Babb,

John Bresnahan,

M A Greenberg,

Albert E. Raizner,

Alan G. Wasserman,

T. Robertson,

Rachael Ross

Publication year - 1992

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.85.2.533

Subject(s) - medicine , timi , myocardial infarction , thrombolysis , cardiology , angioplasty , infarction , cardiac catheterization , clinical endpoint , surgery , randomized controlled trial

The Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial randomized 3,339 patients to either an invasive (INV, n = 1,681) or a conservative (CON, n = 1,658) strategy after intravenous recombinant tissue-type plasminogen activator (rt-PA) for acute myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research